Your cart is currently empty!
Acriptega for HIV treatment Acriptega includes Dolutegravir/Lamivudine/Tenofovir is a fixed-dose combination medication used for the treatment of HIV (Human Immunodeficiency Virus) infection. It is also known by its brand name Tivicay®, Lamivir®, Tenof®. This combination drug contains three active ingredients: Dolutegravir: Dolutegravir is an integrase strand transfer inhibitor (INSTI) antiretroviral drug. It works by blocking…
Acriptega for HIV treatment
Acriptega includes Dolutegravir/Lamivudine/Tenofovir is a fixed-dose combination medication used for the treatment of HIV (Human Immunodeficiency Virus) infection. It is also known by its brand name Tivicay®, Lamivir®, Tenof®. This combination drug contains three active ingredients:
The combination of Dolutegravir/Lamivudine/Tenofovir provides a complete antiretroviral regimen in a single pill, making it easier for patients to adhere to their treatment schedule. It is indicated for the treatment of HIV-1 infection in adults who have not previously received antiretroviral therapy or in those who are virologically suppressed and wish to switch to a new regimen.
As with any HIV treatment, the decision to use Acriptega (Dolutegravir/Lamivudine/Tenofovir) or any other antiretroviral medication should be made by a qualified healthcare professional based on an individual’s medical history, viral resistance testing, and treatment goals. Regular monitoring of viral load and CD4 cell counts is essential to assess the effectiveness of the medication and overall HIV management.